A trial testing the drug JL15003 for glioblastoma that has come back
Original title: A Phase Ib/II Clinical Trial to Evaluate the Safety and Efficacy of JL15003 Injection in Patients With Recurrent Glioblastoma (rGBM)
How far along is this research?
This is a trial that is enrolling or has been updated. It is not a finding yet.
This is an early test in people, and it looks at safety first.
Status: Recruiting. It is looking for patients now. Talk to your care team about whether it fits you.
The trial team last updated this record on . Always check the trial page for the latest.
The short version
This trial is testing a drug called JL15003 in people whose glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary has returned.
Who this trial is for. This trial is for people who have glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary that has come back. It is testing a drug given as an injection, called JL15003. The trial is looking at how safe the drug is and whether it helps.
Where it stands. The trial has not reported results. It is measuring how safe JL15003 is and how well it works. Those answers are not in yet.
What this means, and what it doesn't
What it could mean: If your glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary has come back, this is one study you could ask your care team about. They know your case and can help you think it through. The trial team decides who can take part.
What it doesn't mean: This does not mean the drug works. A trial is a test, not a proven treatment. Being in a trial is not a guarantee that you will be helped. It is not a promise of a cure.
Source: ClinicalTrials.gov, August 10, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.